Safety and feasibility of nephrectomy after receipt of immune checkpoint inhibitors for renal cell carcinoma.

被引：3
|
作者：
Singla, Nirmish [1 ]
Elias, Roy [1 ]
Ghandour, Rashed [1 ]
Freifeld, Yuval N. [1 ]
Bowman, Alex Isaac [1 ]
Woldu, Solomon L. [1 ]
Gahan, Jeffrey [1 ]
Bagrodia, Aditya [1 ]
Brugarolas, James [1 ]
Hammers, Hans J. [1 ]
Margulis, Vitaly [1 ]
机构：
[1] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 07期
关键词：
D O I：
10.1200/JCO.2019.37.7_suppl.619
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
619
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Effects of Immune Checkpoint Inhibitors on Histopathology of Renal Cell Carcinoma
    Setoodeh, Sasan
    Przybycin, Christopher
    Elias, Roy
    Rini, Brian
    Brugarolas, James
    Kapur, Payal
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 971 - 972
  • [22] Effects of Immune Checkpoint Inhibitors on Histopathology of Renal Cell Carcinoma
    Setoodeh, Sasan
    Przybycin, Christopher
    Elias, Roy
    Rini, Brian
    Brugarolas, James
    Kapur, Payal
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 971 - 972
  • [23] Cell proliferation as a biomarker for response to immune checkpoint inhibitors in PD-L1 negative renal cell carcinoma.
    Glenn, Sean T.
    Pabla, Sarabjot
    Zhu, Jason
    Labriola, Matthew
    Gupta, Rajan
    George, Daniel J.
    McCall, Shannon
    Yau, Edwin
    Conroy, Jeffrey M.
    Nesline, Mary
    Papanicolau-Sengos, Antonios
    Burgher, Blake
    Lenzo, Felicia L.
    Zhang, Tian
    Morrison, Carl
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (08)
  • [24] Re: Oncological Outcomes of Delayed Nephrectomy After Optimal Response to Immune Checkpoint Inhibitors for Metastatic Renal Cell Carcinoma Editorial Comment
    Laguna, M. Pilar
    Pignot, G.
    Thiery-Vuillemin, A.
    Albiges, L.
    JOURNAL OF UROLOGY, 2023, 210 (01): : 216 - 216
  • [25] Patterns of failure analysis after radical nephrectomy for renal cell carcinoma.
    Jhavar, Sameer G.
    Swanson, Gregory P.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [26] Clinical outcomes of tyrosine kinase inhibitors immediately after immune checkpoint inhibitors in renal cell carcinoma
    Kato, Taigo
    Nagahara, Akira
    Kawamura, Norihiko
    Nakata, Wataru
    Soda, Tetsuji
    Matsuzaki, Kyousuke
    Hatano, Koji
    Kawashima, Atsunari
    Ujike, Takeshi
    Nishimura, Kensaku
    Takada, Shingo
    Tsujihata, Masao
    Yamaguchi, Seiji
    Takao, Tetsuya
    Nakai, Yasutomo
    Nakayama, Masashi
    Uemura, Motohide
    Nonomura, Norio
    ANNALS OF ONCOLOGY, 2022, 33 : S497 - S497
  • [27] Feasibility and Safety of Robotic Excision of Ipsilateral Retroperitoneal Recurrence After Nephrectomy for Renal Cell Carcinoma
    Ghandour, Rashed
    Miranda, Andre Filipe
    Singla, Nirmish
    Meng, Xiaosong
    Enikeev, Dmitry
    Woldu, Solomon
    Bagrodia, Aditya
    Cadeddu, Jeffrey
    Gahan, Jeffrey
    Margulis, Vitaly
    UROLOGY, 2020, 145 : 159 - 165
  • [28] Multi-omic characterization of acquired resistance to immune checkpoint inhibitors in patients with metastatic renal cell carcinoma.
    Saad, Eddy
    Labaki, Chris
    Miron, Benjamin
    Park, Jihye
    Bakouny, Ziad
    Nassar, Amin
    Saliby, Renee Maria
    Semaan, Karl
    Eid, Marc
    Meli, Kevin
    Laimon, Yasmin Nabil
    Geynisman, Daniel M.
    Kokate, Rutika
    Braun, David A.
    Signoretti, Sabina
    Mcgregor, Bradley Alexander
    Plimack, Elizabeth R.
    Choueiri, Toni K.
    Van Allen, Eliezer Mendel
    Zibelman, Matthew R.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL)
  • [29] Metabolic determinants of exceptional response to immune checkpoint inhibition in renal cell carcinoma.
    Saliby, Renee Maria
    Labaki, Chris
    Jammihal, Tejas
    Soulati, Hanna
    Gallegos, Juan
    Peris, Arnau
    McCurry, Dustin Barrett
    Shah, Valisha
    Poduval, Deepak
    El Zarif, Talal
    El Ahmar, Nourhan
    Laimon, Yasmin Nabil
    Sheshdeh, Aseman Bagheri
    Eid, Marc
    Krajewski, Katherine
    Signoretti, Sabina
    Van Allen, Eliezer
    Shukla, Sachet A.
    Choueiri, Toni K.
    Braun, David A.
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (5_SUPPL)
  • [30] Safety and efficacy of restarting immune checkpoint inhibitors after clinically significant immune-related adverse events in metastatic renal cell carcinoma
    Abou Alaiwi, Sarah
    Xie, Wanling
    Nassar, Amin H.
    Dudani, Shaan
    Martini, Dylan
    Bakouny, Ziad
    Steinharter, John A.
    Nuzzo, Pier Vitale
    Flippot, Ronan
    Martinez-Chanza, Nieves
    Wei, Xiao
    McGregor, Bradley A.
    Kaymakcalan, Marina D.
    Heng, Daniel Y. C.
    Bilen, Mehmet A.
    Choueiri, Toni K.
    Harshman, Lauren C.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (01)
12345